Automate and standardize your regulatory management, from correspondence and commitments to registration and tracking.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESUncertainty, risk, financial constraints, limited human resources, and investor pressure—do these challenges sound familiar? Unfortunately, this is a common situation for small and emerging pharma and biotech companies with promising pipeline assets. This situation might make them think twice before investing and make them deprioritize a key tool that can help them make important decisions moving forward. This tool is a well-established clinical development plan (CDP).
And what is a CDP? A clinical development plan (CDP) is a dynamic, strategic document that outlines the progression of a clinical development program from preliminary research to conclusive studies. It serves as a roadmap for the development of a new drug or medical device, detailing the necessary steps to ensure regulatory compliance, optimize resource allocation, and mitigate risks.
Many small and emergent pharma and biotech companies often delay the creation of a CDP until they have positive data, but this decision can backfire. Having a CDP as early as possible and keeping it updated, helps them ensure they have a clear objective, and that every planned action in their roadmap is aligned with achieving that goal.
Truly valuable CDPs are scenario driven and bring clarity for timelines, key milestones, endpoint strategy, regulatory strategy, statistical modeling, study design concept, interim decision points, risks and contingencies, and alignment to strategic goals.
In an environment where every dollar, euro, yen and yuan needs to be efficiently invested to maximize the probability of making the right decisions, early CDP planning can ensure:
In conclusion, for small and emerging biotech and pharma companies, while resources are tight, an early CDP should be considered a strategic imperative, and not a luxury. It can act as a roadmap to navigate the complexities of drug development, ensuring all the planned actions are focused on achieving the key goals, attracting investors with a clear vision and satisfying regulators with meticulous planning.
By proactively addressing risks and optimizing resources, the CDP significantly increases the chances of bringing innovative therapies to patients and achieving sustainable success.
Automate and standardize your regulatory management, from correspondence and commitments to registration and tracking.
Reimagine regulatory service delivery.